3 Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks With a Strong Future Roadmap: Suraksha Diagnostic, Ultramarine & Pigments and Godrej Consumer Products
- October 16, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Suraksha Diagnostic Rs 307.65, P/E 46.05. Ultramarine Rs 392.70, P/E 12.67. Godrej Consumer Rs 869.40, P/E 46.25. Closing prices of 14 Oct 2026.
Quick Answer
Diagnostic chain, colourant maker and hair colour brand stocks with the clearest long-term roadmaps today include Suraksha Diagnostic in diagnostic and pathology testing through a network of labs and collection centres, Ultramarine in ultramarine blue pigments and related colourants for plastics, paints and detergents and Godrej Consumer in household insecticides, soaps and hair colour sold in India, Indonesia and Africa. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 11.2% at Ultramarine and 7.9% at Godrej Consumer. P/E stands at 46.05 for Suraksha Diagnostic (industry 62.79), 12.67 for Ultramarine (industry 36.60) and 46.25 for Godrej Consumer (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.
Diagnostic chain, colourant maker and hair colour brand stocks give investors exposure to health tests, colourants and household brands used every day. Volumes, lab additions and margins decide how much of that demand turns into profit.
Readers comparing diagnostic chain, colourant maker and hair colour brand stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.
This list covers three diagnostic chain, colourant maker and hair colour brand stocks: Suraksha Diagnostic for diagnostic and pathology testing through a network of labs and collection centres, Ultramarine & Pigments for ultramarine blue pigments and related colourants for plastics, paints and detergents and Godrej Consumer Products for household insecticides, soaps and hair colour sold in India, Indonesia and Africa. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks?
Diagnostic chain, colourant maker and hair colour brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.
Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three diagnostic chain, colourant maker and hair colour brand stocks as of the 14 Oct 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| Suraksha Diagnostic | 307.65 | 1,614 | 46.05 | 62.79 | 13.15% | 0.53 |
| Ultramarine & Pigments | 392.70 | 1,168 | 12.67 | 36.60 | 9.29% | 0.10 |
| Godrej Consumer Products | 869.40 | 88,506 | 46.25 | 34.85 | 14.71% | 0.35 |
Among healthcare, chemicals and consumer stocks, Godrej Consumer trades at a premium to the industry P/E, while Suraksha Diagnostic and Ultramarine trade at a discount.
Why Do Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks Have a Strong Roadmap in India?
Diagnostic chain, colourant maker and hair colour brand stocks have a strong roadmap in India because preventive health checks, detergent and paint output and household brand spending keep adding volumes for these firms. Three drivers stand out.
- Preventive health: Families test more often and earlier.
- Industrial colour: Detergents, plastics and paints use pigments.
- Household brands: Insecticides, soaps and hair colour sell across markets.
Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline
Suraksha Diagnostic’s roadmap rests on diagnostic and pathology testing through a network of labs and collection centres, with rising health screening supporting test volumes.
Revenue grew from Rs 225.50 crore in FY22 to Rs 313.58 crore in FY26, a 39.1% rise, and FY26 revenue was 22.5% higher than FY25. FY26 net profit rose 1.4% to Rs 31.40 crore. Over four years, net profit rose from Rs 23.75 crore in FY22 to Rs 31.40 crore. In Q1 FY27, revenue grew 20.7% to Rs 88.74 crore, and net profit rose 40.0% to Rs 12.85 crore. Operating margin was 32.01% in FY26 and 35.97% in Q1 FY27 against 33.97% a year earlier.
Debt to equity is 0.53 and return on equity is 13.15%. FY26 operating cash flow was Rs 81.83 crore against capital expenditure of Rs 67.34 crore. Suraksha Diagnostic paid a dividend of Rs 0.05 per share for FY26, a yield of 0.02%. At a P/E of 46.05 against an industry P/E of 62.79, the stock trades below its industry multiple.
What to watch: Q1 FY27 operating margin was 35.97% against 32.01% for FY26, so margin stability is the figure to follow as volumes grow.
Ultramarine & Pigments: Pigments for Plastics and Paints Drive the Pipeline
Ultramarine’s roadmap rests on ultramarine blue pigments and related colourants for plastics, paints and detergents, with steady industrial demand supporting volumes.
Revenue grew from Rs 499.48 crore in FY22 to Rs 786.41 crore in FY26, a 57.4% rise, and FY26 revenue was 11.2% higher than FY25. FY26 net profit rose 7.6% to Rs 80.77 crore. Over four years, net profit rose from Rs 58.30 crore in FY22 to Rs 80.77 crore. In Q1 FY27, revenue grew 31.2% to Rs 245.68 crore, and net profit rose 56.5% to Rs 31.59 crore. Operating margin was 17.91% in FY26 and 21.33% in Q1 FY27 against 18.78% a year earlier.
Debt to equity is 0.10 and return on equity is 9.29%. FY26 operating cash flow was Rs 128.27 crore against capital expenditure of Rs 67.87 crore. Ultramarine paid a dividend of Rs 6 per share for FY26, a yield of 1.50%. At a P/E of 12.67 against an industry P/E of 36.60, the stock trades below its industry multiple.
What to watch: Q1 FY27 operating margin was 21.33% against 17.91% for FY26, so margin stability is the figure to follow as volumes grow.
Godrej Consumer Products: Household and Personal Care Brands Drive the Pipeline
Godrej Consumer’s roadmap rests on household insecticides, soaps and hair colour sold in India, Indonesia and Africa, with a multi-country brand portfolio supporting sales.
Revenue grew from Rs 12,366.21 crore in FY22 to Rs 15,444.07 crore in FY26, a 24.9% rise, and FY26 revenue was 7.9% higher than FY25. FY26 net profit was Rs 1,861.47 crore. In Q1 FY27, revenue grew 14.2% to Rs 4,277.35 crore, and net profit rose 11.5% to Rs 504.52 crore. Operating margin was 19.45% in FY26.
Debt to equity is 0.35 and return on equity is 14.71%. FY26 operating cash flow was Rs 2,488.47 crore against capital expenditure of Rs 569.53 crore. Godrej Consumer paid a dividend of Rs 20 per share for FY26, a yield of 2.31%. At a P/E of 46.25 against an industry P/E of 34.85, the stock trades above its industry multiple.
What to watch: The P/E of 46.25 sits above the industry P/E of 34.85, so earnings delivery matters for the valuation.
Best Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks in India: Suraksha Diagnostic vs Ultramarine vs Godrej Consumer on Key Financials
Among the best diagnostic chain, colourant maker and hair colour brand stocks in India, Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; Ultramarine leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; Godrej Consumer leads on return on equity and dividend yield. The table puts the numbers side by side.
| Metric | Suraksha Diagnostic | Ultramarine | Godrej Consumer |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 313.58 | 786.41 | 15,444.07 |
| FY26 revenue growth | 22.5% | 11.2% | 7.9% |
| FY26 net profit (Rs Cr) | 31.40 | 80.77 | 1,861.47 |
| FY26 operating profit margin | 32.01% | 17.91% | 19.45% |
| Q1 FY27 revenue growth (YoY) | 20.7% | 31.2% | 14.2% |
| Q1 FY27 net profit growth (YoY) | 40.0% | 56.5% | 11.5% |
| Return on equity | 13.15% | 9.29% | 14.71% |
| P/E ratio | 46.05 | 12.67 | 46.25 |
| Debt to equity | 0.53 | 0.10 | 0.35 |
| Dividend yield | 0.02% | 1.50% | 2.31% |
| FY26 operating cash flow (Rs Cr) | 81.83 | 128.27 | 2,488.47 |
Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.
How to Evaluate Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen diagnostic chain, colourant maker and hair colour brand stocks and shortlist diagnostic chain, colourant maker and hair colour brand stocks to buy.
- Compare each stock’s P/E with its industry P/E, which differs by company here.
- Check revenue growth, operating margin and cash flow together.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read operating cash flow against capital expenditure to see how growth is funded.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Risks to Consider Before Investing in Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks
- Consumer demand: Spending patterns can shift sales between quarters.
- Input costs: Changes in raw material prices can affect margins.
- Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.
Download the Univest iOS App or Univest Android App to track Suraksha Diagnostic, Ultramarine and Godrej Consumer live.
Final Take: Which Stock Has the Strongest Roadmap?
These three healthcare, chemicals and consumer stocks cover diagnostics, colourants and household brands. Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; Ultramarine leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; Godrej Consumer leads on return on equity and dividend yield.
Across diagnostic chain, colourant maker and hair colour brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the diagnostic chain, colourant maker and hair colour brand stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Diagnostic Chain, Colourant Maker and Hair Colour Brand Stocks
Which are the best diagnostic chain, colourant maker and hair colour brand stocks in India with a strong roadmap?
Ans. Suraksha Diagnostic, Ultramarine & Pigments and Godrej Consumer Products stand out for their roadmaps in diagnostics, colourants and household brands. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 11.2% at Ultramarine and 7.9% at Godrej Consumer, and return on equity ranges from 9.29% to 14.71%.
Is Suraksha Diagnostic a good stock to buy now?
Ans. Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P/E of 46.05 against an industry P/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of Suraksha Diagnostic, Ultramarine and Godrej Consumer?
Ans. The P/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 12.67 for Ultramarine (industry 36.60) and 46.25 for Godrej Consumer (industry 34.85). Only Godrej Consumer trades at or above the industry multiple.
Which of these diagnostic chain, colourant maker and hair colour brand stocks has the highest return on equity?
Ans. Godrej Consumer Products has the highest return on equity at 14.71%, followed by Suraksha Diagnostic at 13.15% and Ultramarine & Pigments at 9.29%.
What are the risks of investing in diagnostic chain, colourant maker and hair colour brand stocks?
Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.
How did Suraksha Diagnostic, Ultramarine and Godrej Consumer perform in Q1 FY27?
Ans. Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. Ultramarine & Pigments reported revenue of Rs 245.68 crore, up 31.2% year on year, and net profit rose 56.5% to Rs 31.59 crore. Godrej Consumer Products reported revenue of Rs 4,277.35 crore, up 14.2% year on year, and net profit rose 11.5% to Rs 504.52 crore.
Do diagnostic chain, colourant maker and hair colour brand stocks pay dividends?
Ans. Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 1.50% for Ultramarine and 2.31% for Godrej Consumer, based on dividends declared for FY26.
How can I invest in diagnostic chain, colourant maker and hair colour brand stocks in India?
Ans. You can buy diagnostic chain, colourant maker and hair colour brand stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.
